Bridging the Gap in Worsening Heart Failure: Evidence-Based Approaches to Optimising Treatment Outcome
Published: 18 September 2024
-
Views:
251
-
Likes:
7
-
Views:
251
-
Likes:
7
-
Up Next -
5m 15sPart 1 | Session 2 Case 2: Worsening Heart Failure – Outpatient Setting -
5m 15sPart 1 | Session 3 Case 3: Worsening Heart Failure - Post-Discharge
-
11m 45s
-
13m 45s
-
17m 42s
-
11m 49s
-
1m 44sPart 6 Session 5 - Closing Remarks
Overview
Radcliffe Medical Education, is proud to bring to you this roundtable series which is designed to equip healthcare professionals with the knowledge and tools necessary to identify high-risk patients indicative of worsening HF and to implement effective management strategies. Watch Dr Javed Butler (Baylor Scott & White Health, Dallas, US); Dr Shelley Zieroth (University of Manitoba, Winnipeg, CA) and Prof Gianluigi Savarese (Karolinska Institute, Stockholm, SE) as they go through a comprehensive exploration of validated assessment tools, prognostic evaluations and emerging treatments.
In support of improving patient care, this activity has been planned and implemented by Radcliffe Cardiology and i3Health. i3 Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
i3 Health and Radcliffe Medical Education planners, reviewers, and managers have nothing to disclosure.
i3 Health and Radcliffe have mitigated all relevant financial relationships.
The live version of this roundtable was accredited, the on-demand version is not.
Key Learning Objectives
- To identify high-risk patient features indicative of worsening Heart Failure (HF)
- Name validated tools for serial prognostic assessment and risk stratification
- Adopt the use of appropriate assessment tools during patient follow-up
- Recall rates of recurrent HF events and their associated healthcare costs in worsening HF patients
- Recall the clinical benefit of emerging treatments targeted to treating worsening HF
- Initiate available treatment for the tailored management of worsening HF
Target Audience
- Cardiologists
- Internists
- Heart Failure Specialists
- General Practitioners
- Nurse Practitioners
- Cardiovascular Nurses
- Healthcare Professionals involved in the management of HF patients
More from this programme
Part 1
Case Studies
Review the case studies on worsening heart failure recorded by Prof Gianluigi Savarese and Dr Javed Butler, prior to the roundtable recording. The faculty will discuss the results during session one of the roundtable.
Part 2
Session 1 - Complex Patient Cases
This first session will see the faculty review their own patient cases detailing the challenging authentic worsening HF cases across multiple settings. The faculty evaluate each case, discussing risk factors, treatment decisions, and providing clinical pearls.
| 1 session | |
| Session 1 - Complex Patient Cases | Watch now |
Part 3
Session 2 - Risk Assessment in Worsening HF
Dr Shelley Zieroth provides an overview on the validating tools for risk stratification and prognosis in worsening HF available at the point of care, providing recommendations for optimal use and timing of assessments during follow-up.
Part 4
Session 3 – Emerging Therapies
Dr Javed Butler provides an overview of the most promising novel pharmacological therapies for reducing events in worsening HFrEF and HFpEF, including key trials and real world implementation considerations.
| 1 session | |
| Session 3 – Emerging Therapies | Watch now |
Part 5
Session 4 - Bridging Treatment Gaps
Gianluigi Savarese provide hte The faculty panel will examine reasons for low uptake of guideline-directed medical therapies in worsening HF and explore evidence-based solutions to addressing barriers around clinical inertia and suboptimal prescribing patterns upon discharge.
| 1 session | |
| Session 4 - Bridging Treatment Gaps | Watch now |
Part 6
Session 5 - Closing Remarks
In the final chapter, the faculty summarise their closing remarks on the roundtable.
| 1 session | |
| Session 5 - Closing Remarks | Watch now |
Faculty Biographies
Javed Butler
Professor of Medicine
Dr Javed Butler is President, Baylor Scott and White Research Institute, Senior Vice President for the Baylor Scott and White Health and Professor of Medicine at the University of Mississippi, US. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure.
He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.
Prof Butler has authored more than 900 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals and has been cited numerous times in America’s Best Doctors list.
Shelley Zieroth
Director, Heart Failure and Heart Transplant Clinics
Dr Shelley Zieroth is Professor at the College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, as well as Director of the Heart Failure and Heart Transplant Clinics at St Boniface Hospital in Winnipeg, Canada. She is also Head of the Medical Heart Failure Program for Cardiac Sciences Manitoba.
She is involved in several heart failure clinical trials as a PI, National Lead or Executive Committee member. She is the Past President of the Canadian Heart Failure Society and Co-Chair of the Canadian Cardiovascular Society Heart Failure Guidelines. She is co-chair of Canada’s largest annual heart failure meeting, HF Update, and Past President of the Federation of Medical Women of Canada.
Dr Shelley Zieroth is an Editorial Board member of Cardiac Failure Review.
Gianluigi Savarese
Associate Professor of Cardiology
Prof Gianluigi Savarese is currently an Associate Professor of Cardiology and Heart Failure Specialist at the Karolinska Institute in Stockholm, Sweden.
Prof Savarese has served on the board for the European Society of Cardiology's Heart Failure Association since 2020, and has previously been a Nucleus member of a working group on Cardiovascular Pharmacotherapy for the ESC. He is a member of the Italian Society of Cardiology, and the Swedish Society of Cardiology.
Prof Savarese attended the University of Naples Federico II University for his degree in Surgery and Medicine between 2004 - 2010. He then went on to stay at the same institution until 2016 as he completed his Specialism in Cardiovascular Diseases. He then continued his postgraduate studies at the University of Zurich between 2015-2017, where he continued his studies into Heart Failure. Finally, Prof Savarese completed his PhD at the Karolinska Institutet in 2018.
Prof Savarese has…
Comments